共 124 条
[5]
Mizoribine may suppress bone erosion in patients with rheumatoid arthritis by inhibiting osteoclastogenesis.[J].Yeon-Ah Lee;Hyung-In Yang;Eun Kyung Park;Jun Soo Bang;Hyun Mi Choi;Da Hee Oh;Sang-Hoon Lee;Seung-Jae Hong;Yoon-Je Jo;Myung Chul Yoo;Kyoung Soo Kim.European Journal of Pharmacology.2008, 1
[6]
FRAX? and the assessment of fracture probability in men and women from the UK.[J].J. A. Kanis;O. Johnell;A. Oden;H. Johansson;E. McCloskey.Osteoporosis International.2008, 4
[7]
Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs - A one-year randomized, placebo-controlled study
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (09)
:2807-2816
[8]
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (09)
:2817-2829
[9]
The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis.[J].Eiji Torikai;Yasunori Kageyama;Masaaki Takahashi;Akira Nagano.Modern Rheumatology.2006, 6
[10]
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (05)
:1390-1400

